Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Assessment of the Cardiovascular System III: Palpation01:27

Assessment of the Cardiovascular System III: Palpation

390
Palpation involves feeling the body to evaluate texture, size, consistency, and tenderness for assessing cardiovascular health. The following steps are organized in a head-to-toe order:
Jugular Venous Pressure (JVP) Measurement
Position the patient at a thirty- to forty-five-degree angle or in a semi-fowler's position. Look for the highest point of pulsation in the internal jugular vein and measure the vertical distance to the angle of Loius or sternal angle. A normal JVP is 3-4 cm above...
390
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

38
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
38
Complement System01:27

Complement System

2.5K
The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a...
2.5K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

11
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
11
Cardiovascular System Abnormal Findings I: Inspection and Palpation01:29

Cardiovascular System Abnormal Findings I: Inspection and Palpation

447
In a cardiovascular examination, inspection and palpation are crucial for identifying abnormalities.
Abnormal findings observed during an inspection
447
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

14
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
14

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sustained clinical remission and relapse of severe eosinophilic asthma following long-term mepolizumab treatment.

Allergology international : official journal of the Japanese Society of Allergology·2026
Same author

Burden of Hereditary Angioedema in Adults: Impact of Disease and Patient Characteristics.

International archives of allergy and immunology·2026
Same author

A Real-World Controlled Multicentre Study Evaluating the Association Between Benralizumab Therapy and Major Outcomes in Severe Asthma.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2026
Same author

Arerugi = [Allergy]·2026
Same author

Prevalence and Sociodemographic Variation of Allergic Diseases in Australia: Findings From the Australian National Health Survey.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2026
Same author

Completion of the Icatibant Outcome Survey and What We Learned.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2026

Related Experiment Video

Updated: Jul 26, 2025

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells
06:29

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells

Published on: January 29, 2014

30.7K

Angioedema With Normal Complement Studies: What Do We Know?

Constance H Katelaris1, Anete S Grumach2, Konrad Bork3

  • 1Immunology/Allergy Unit, Department of Medicine, Campbelltown Hospital and Faculty of Medicine, Western Sydney University, Campbelltown, New South Wales, Australia.

The Journal of Allergy and Clinical Immunology. in Practice
|June 21, 2023
PubMed
Summary

Angioedema is a localized swelling caused by increased vascular permeability. It can be mast cell-mediated or bradykinin-driven, with distinct clinical presentations and management strategies.

Keywords:
AngioedemaDiagnosisGeneticHereditary angioedemaHereditary angioedema with normal C1 inhibitor

More Related Videos

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
09:43

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Published on: June 8, 2022

3.0K
Intravital Microscopy of the Inguinal Lymph Node
07:34

Intravital Microscopy of the Inguinal Lymph Node

Published on: April 4, 2011

20.3K

Related Experiment Videos

Last Updated: Jul 26, 2025

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells
06:29

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells

Published on: January 29, 2014

30.7K
Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
09:43

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Published on: June 8, 2022

3.0K
Intravital Microscopy of the Inguinal Lymph Node
07:34

Intravital Microscopy of the Inguinal Lymph Node

Published on: April 4, 2011

20.3K

Area of Science:

  • Immunology
  • Vascular Biology
  • Dermatology

Background:

  • Angioedema is characterized by localized, non-pitting edema due to increased vascular permeability.
  • It can arise from various mechanisms, sometimes mimicking other conditions.
  • Classification begins by identifying concurrent urticaria or wheals.

Purpose of the Study:

  • To outline the clinical recognition and classification of angioedema.
  • To differentiate between mast cell-mediated and bradykinin-driven angioedema.
  • To highlight diagnostic approaches and challenges in managing angioedema.

Main Methods:

  • Clinical observation and classification based on urticaria presence.
  • Pathogenesis categorization into mast cell-mediated and bradykinin-driven.
  • Diagnostic considerations including C4 and C1 inhibitor testing for hereditary angioedema.

Main Results:

  • Angioedema pathogenesis is broadly divided into mast cell-mediated (often with urticaria) and bradykinin-driven (without urticaria).
  • Bradykinin-mediated angioedema, including hereditary forms, does not respond to antiallergic treatments.
  • Angiotensin converting enzyme inhibitors are a significant cause of angioedema.

Conclusions:

  • Accurate angioedema classification is crucial for appropriate management.
  • Distinguishing between mast cell-mediated and bradykinin-driven pathways guides therapeutic decisions.
  • Further research is needed for managing angioedema with unknown mechanisms.